| ID | Name | CAS | Data |
Inp |
| 17-728-5 |
Perhydrophenanthrene, 1B-(3R,7-dimethylnonyl)-2A,4bB,8,8,10aB-pentamethyl
|
|
5 | 2970.00 |
| 17-914-8 |
3-Chloro-2-fluorobenzoic acid, 2,2,3,3,4,4,5,5-octafluoropentyl ester
|
|
5 | 1506.00 |
| 17-916-6 |
1-Oxa-spiro[4.5]deca-6,9-diene-2,8-dione, 7,9-di-tert-butyl-
|
|
5 | [1916.80; 1929.00] |
| 18-089-4 |
3-Chloro-2-fluorobenzoic acid, 2,3,4,6-tetrachlorophenyl ester
|
|
5 | 2541.00 |
| 18-200-9 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,3-dimethyl-butyl)-amine
|
|
5 | [1702.15; 1740.74] |
| 18-207-2 |
Fumaric acid, monoamide, N-(2-fluorophenyl)-, 2-bromo-4-fluorophenyl ester
|
|
5 | 2724.00 |
| 18-293-7 |
2-Propen-1-ol, 3-(4-hydroxy-3-methoxyphenyl), bis-TMS
|
|
5 | [1935.00; 1942.80] |
| 18-315-2 |
Benzamide, N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxy-
|
138-56-7 |
5 | 3287.00 |
| 18-400-7 |
Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, 2-methyl-4-oxo-3-(2,4-pentadienyl)-2-cyclopenten-1-yl ester, [1R-[1«alpha»[S*(Z)],3«beta»]]-
|
121-21-1 |
5 | [2297.00; 2314.00] |
| 18-402-5 |
Silane, dimethyl(dimethyl(3-phenylpro-2-enyloxy)silyloxy)(3-phenylpro-2-enyloxy)-
|
|
5 | 2538.00 |
| 18-521-3 |
(+)-(1R,6S,7S,10S)-7«beta»-Hydroxyamorpha-4,11-diene
|
|
5 | 1614.00 |
| 18-577-2 |
Trimethylsilyl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitro-benzoate
|
|
5 | 2320.00 |
| 18-787-9 |
Glutaric acid, 2-methylhex-3-yl 3-methyl-4-nitrobenzyl ester
|
|
5 | 3084.00 |
| 18-793-2 |
4,8-Methanoazulen-9-ol, decahydro-2,2,4,8-tetramethyl-, stereoisomer
|
4586-22-5 |
5 | [1554.00; 1569.00] |
| 18-862-5 |
Methyl-2«alpha»-[2'(m-isopropylphenyl)ethyl]-1«beta»,3«alpha»-dimethylcyclohexanecarboxylate
|
|
5 | 2130.00 |
| 18-939-0 |
(6E,11E)-2,3,6,10,13,20,21-heptamethyl-17-methylene-13-vinyl-1,6,11,21-docosatetraene
|
|
5 | 2689.00 |
| 18-948-0 |
[3-(10,11-Dihydro-dibenzo[b,f]azepin-5-yl)-2-methyl-propyl]-methyl-amine
|
|
5 | 2270.00 |
| 18-978-7 |
3-Fluoro-4-trifluoromethylbenzoic acid, 2,4-dichloronaphth-1-yl ester
|
|
5 | 2453.00 |
| 19-097-4 |
6-Bromohexanoic acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester
|
|
5 | 1996.00 |
| 19-386-3 |
Cyclopentanol, 1,2-dimethyl-3-(1-methylethenyl)-, [1R-(1«alpha»,2«alpha»,3«alpha»)]-
|
4028-60-8 |
5 | 1155.00 |
| 19-491-6 |
trans-1-t-butyl-peroxy-p-mentha-2,8-diene
|
|
5 | 1398.00 |
| 19-607-7 |
1,3,5(10)-Oestratriene-3,17«beta»-diol, 3-TMS-17-HFB
|
|
5 | 2593.00 |
| 19-634-7 |
9H-Naphtho[2,1-b]pyran-9-one, 3-ethenyldodecahydro-3,4a,7,7,10a-pentamethyl-, [3R-(3«alpha»,4a«beta»,6a«alpha»,10a«beta»,10b«alpha»)]-
|
1231-34-1 |
5 | [2206.00; 2208.00] |
| 19-653-6 |
Cyclohexyl 2-deoxy-3,4,6-tri-O-methyl-2-(N-methylacetamido)-«alpha»-D-glucopyranoside
|
|
5 | 2419.86 |
| 19-692-3 |
L-Glutamine, N(«alpha»)-trifluoroacetyl-, 2,2,3,3,3-pentafluoropropyl ester
|
|
5 | 1552.70 |
| 19-768-9 |
3«alpha»,17«alpha»,20«alpha»,21-tetrahydroxy-5«beta»-Pregnane-11-one
|
|
5 | 3059.00 |
| 20-327-6 |
(E, E)-3,7,11-Trimethyl-7,10-epoxydodeca-2,5,11-trien-1-yl acetate
|
|
5 | 1816.00 |
| 20-333-9 |
Bicyclo[3.1.1]heptan-2-ol, 2,6,6-trimethyl-
|
473-54-1 |
5 | [1114.00; 1145.00] |
| 20-379-9 |
11-keto-etiocholanolone, 3«alpha»-hydroxy-5«beta»-androstane-11,17-dione
|
|
5 | 2634.00 |
| 20-539-1 |
4-(«alpha»-Ethyl-5-phenyl-1H-pyrrol-3-yl)-pyridine
|
|
5 | 1824.00 |
| 20-595-9 |
endo-2-(1,1-Dimethylprop-2-ynyloxycarbonyl)bicyclo-2.2.1]hept-5-ene
|
|
5 | 1268.00 |
| 20-618-3 |
ent-Kaurenoic acid, 16,17-dlhydro, 7.alpha., 16.beta.,17-triol, Me
|
|
5 | 2860.00 |
| 20-623-7 |
Disiloxane, 1,3-bis(chloromethyl)-1,1,3,3-tetramethyl-
|
|
5 | 1144.00 |
| 20-639-0 |
D-Cysteine, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
5 | 2066.10 |
| 20-676-9 |
Succinic acid, 2-bromo-4-fluorophenyl N,N-diethyl-2-aminoethyl ester
|
|
5 | 2373.00 |
| 20-736-2 |
4-.alpha.,24-Dimethylcholest-8,14-dien-3-.beta.-ol
|
|
5 | 3280.00 |
| 20-908-1 |
Fumaric acid, monoamide, N-allyl-, 2-bromo-4-fluorophenyl ester
|
|
5 | 2336.00 |
| 21-051-1 |
3-Fluoro-5-trifluoromethylbenzoic acid, 2-(1-phenyleth-1-yl)-4-methoxyphenyl ester
|
|
5 | 2431.00 |
| 21-052-0 |
N-(3-Bromo-4-hydroxy-phenyl)-4-nitro-benzenesulfonamide, O,N-di(pentafluoropropionyl)-
|
|
5 | 2347.00 |
| 21-053-9 |
24-Methyl-5-«alpha»-cholest-8-en-3-«beta»-ol
|
|
5 | 3260.00 |
| 21-098-0 |
5-hydroxy-4,6,6-trimethyl-4-cyclohexene-1,3-dione
|
|
5 | 1092.00 |
| 21-240-1 |
2,6-Pyridinedicarboxylic acid, 4-bromo-2-methoxybenzyl pentyl ester
|
|
5 | 3060.00 |
| 21-331-0 |
(+)-(1R,4R,6R,7R,10S)-Muurolan-4,7-peroxide
|
|
5 | 1485.00 |
| 21-386-0 |
2,2,3-exo,5,5,8c,9b,10a,10b-nonachlorobornane
|
|
5 | 2498.20 |
| 21-544-4 |
Glutaric acid, 3,5-dinitrobenzyl 2-methylhex-3-yl ester
|
|
5 | 2947.00 |
| 21-562-4 |
cis-5,8,11,14,17-Eicosapentaenoic acid, 4,4-dimethyloxazoline (dmox) derivative
|
|
5 | 2472.00 |
| 21-578-7 |
6-Chloro-N-sec-butyl-1,3,5-triazine-2,4-diamine
|
37019-18-4 |
5 | 1780.00 |
| 21-882-9 |
17«beta»(H),21«beta»(H)-Bishomohopanoic acid methyl ester
|
|
5 | 3842.00 |
| 21-919-8 |
2-exo,3-endo,6-exo,8b,9c,10a-hexachlorobornane
|
|
5 | 2088.30 |
| 21-986-4 |
24-Ethylcholesta-8,14,24(28)-trien-3-.beta.-ol
|
|
5 | 3320.00 |
| 22-145-6 |
1-Methyl-4-methylenebicyclo[3.2.1]oct-2-ene
|
|
5 | 964.00 |
| 22-195-1 |
Bicyclo[2.2.1]heptan-2-ol, 1,5,5-trimethyl-
|
6168-62-3 |
5 | [1114.00; 1119.00] |
| 22-285-1 |
10-epi-Cubenol-12-nor-Ziza-6(13)-en-2-«beta»-ol
|
|
5 | 1598.00 |
| 22-517-3 |
2,3,4-Trifluorobenzoic acid, oct-3-en-2-yl ester
|
|
5 | 1650.90 |
| 22-563-2 |
Glutaric acid monoamide, N-(1,2,3,4-tetrahydronaphth-1-yl)-, isohexyl ester
|
|
5 | 2813.00 |
| 22-590-2 |
[1R-[1«alpha»,3«alpha»,4«beta»]]-4-Ethenyl-«alpha»,«alpha»,4-trimethyl-3-[1-methylethenyl]cyclohexanemethanol
|
|
5 | [1552.40; 1556.30] |
| 22-641-5 |
3-Chloro-2-fluorobenzoic acid, 2-(1-phenyleth-1-yl)-4-methoxyphenyl ester
|
|
5 | 2877.00 |
| 22-729-8 |
6H-Dibenzo(b,d)pyran-1-ol, 3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-
|
117-51-1 |
5 | 2616.00 |
| 22-828-8 |
N,N'-[Methylenebis(2-chloro-4,1-phenylene)]tetra(2,2,2-trifluoroacetamide)
|
|
5 | 2204.00 |
| 22-938-6 |
(-)-(4S,5R,10R)-6,7-seco-Eudesm-7(11)-en-6-al
|
|
5 | 1614.00 |
| 22-998-0 |
2,6-Pyridinedicarboxylic acid, isobutyl 5-methoxy-3-methylpent-2-yl ester
|
|
5 | 2291.00 |
| 23-066-3 |
4-iodo-2,5-dimethoxy-«beta»-phenethylamine-M, (O-desmethyl-), isomer 2, di-TFA
|
|
5 | 2010.00 |
| 23-075-3 |
Avenaciolide, 1-dihydro-6-[2-(4-trifluoromethylphenyl)ethyl]-4-demethylene
|
|
5 | 2175.00 |
| 23-077-1 |
4-(2,7,7-Trimethylbicyclo[3.2.0]hept-2-en-1-yl)but-3-en-2-one
|
|
5 | [1394.00; 1472.00] |
| 23-182-4 |
2,4,5-Trifluoro-3-methoxybenzamide, N,N-di(2-ethylhexyl)-
|
|
5 | 2461.00 |
| 23-218-4 |
9-tert-Butyl-1-oxaspiro[4.5]deca-6,9-dien-2,8-dione
|
|
5 | [1929.00; 1932.00] |
| 23-423-6 |
1,2,4a,9-Tetramethyl-1,2,3,4,4a,5,6,14b-octahydro-picene
|
|
5 | 3099.27 |
| 23-639-7 |
[14C] GA25 16.alpha., 17-H2, 17-OH , methyl ester
|
|
5 | [2738.00; 2760.00] |
| 23-715-2 |
Cylobutanecarboxylic acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester
|
|
5 | 1604.00 |
| 23-740-4 |
cis-2-t-butyl-peroxy-p-mentha-1(7),8-diene
|
|
5 | 1300.00 |
| 23-827-8 |
7«alpha»H-Eremophila-1(10),11-dien-2-«alpha»-yl methyl ether
|
|
5 | 1686.00 |
| 23-872-8 |
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-
|
20971-53-3 |
5 | [2688.00; 2766.70] |
| 23-909-7 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-dimethyl, 1,3-bis-(chloromethyl)
|
|
5 | 1390.00 |
| 23-943-9 |
Morphinan, 7,8-didehydro-4,5-epoxy-17-methyl-3,6-bis[(trimethylsilyl)oxy]-, (5«alpha»,6«alpha»)-
|
55449-66-6 |
5 | [2513.00; 2550.00] |
| 24-045-5 |
1-Deoxy-1-(methylamino)-D-galactitol, N,O,O,O,O,O-hexa(trifluoroacetyl)-
|
|
5 | 1293.50 |
| 24-124-7 |
3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl), PFBO # 2
|
|
5 | 2076.00 |
| 24-177-9 |
1-Naphthalenecarboxylic acid, decahydro-1,4a-dimethyl-6-methylene-5-(3-methyl-2,4-pentadienyl)-, methyl ester, [1S-[1«alpha»,4a«alpha»,5«alpha»(E),8a«beta»]]-
|
15798-13-7 |
5 | [2234.00; 2256.00] |
| 24-193-1 |
3,6,9,12-Tetraoxa-2,13-disilatetradecane, 2,2,13,13-tetramethyl-
|
|
5 | 1489.10 |
| 24-194-0 |
24-Ethyl-5-«alpha»-cholest-8(14)-en-3-«beta»-ol
|
78340-86-0 |
5 | 3300.00 |
| 24-249-9 |
1,2-Dithiolan-4-one, 3,5-dimethyl, #2 (E or Z)
|
|
5 | 1105.00 |
| 24-435-2 |
Podocarp-7-en-3.beta.-ol, 13.beta.-methyl-13-vinyl-
|
|
5 | 2253.00 |
| 24-512-6 |
1,2-Cyclohexanediol, 4-methyl-1-(1-methylethyl)-, (1«alpha»,2«alpha»,4«alpha»)-
|
42962-98-1 |
5 | 1395.00 |
| 24-563-0 |
2,2,5-endo,6-exo,8b,8c,9c,10a,10c-nonachlorobornane
|
|
5 | 2483.90 |
| 24-767-4 |
24-Methyl-5-«alpha»-cholesta-8,24(28)-dien-3-«beta»-ol
|
|
5 | 3230.00 |
| 25-244-3 |
(R)-2-Butyl 2-deoxy-3,4,6-tri-O-methyl-2-(N-methylacetamido)-[3-o-glucopyranoside
|
|
5 | 1968.96 |
| 25-267-8 |
Diethylmalonic acid, monochloride, 2,2,3,3,4,4,5,5-octafluoropentyl ester
|
|
5 | 1249.00 |
| 25-387-5 |
Methyl 2-(2,2-dimethyl-1,3-dioxolan-4-yl)-2-(ethoxycarbonyloxy)acetate
|
|
5 | 1527.00 |
| 25-411-7 |
N*1*-[4-(4-Amino-butylamino)-butyl]-butane-1,4-diamine, tetrakis-MOC derivative
|
|
5 | 3268.00 |
| 26-139-9 |
4-Hydroxy-2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde
|
|
5 | 1344.00 |
| 26-203-7 |
Stigmasta-7,25-dien-3-ol, (3.beta.,5.alpha.)-
|
|
5 | 3325.00 |
| 26-219-0 |
24-Ethyl-5-.alpha.-cholest-8-en-3-.beta.-ol
|
|
5 | 3320.00 |
| 26-308-1 |
L-Isoleucine, N-trifluoroacetyl-, 2,2,3,3,3-pentafluoropropyl ester
|
|
5 | 1074.70 |
| 26-361-2 |
Methyl (4S,5R)-2,2,5-trimethyl-1,3-dioxolane-4-carboxylate
|
38410-80-9 |
5 | 1037.50 |
| 26-444-0 |
1 «alpha»,7 «beta»,9 «alpha»-1-Hydroxy-3,6,6,9-tetramethylbicyclo-[5.4.0]undec-3-en-8-one
|
|
5 | 1690.00 |
| 26-475-6 |
6-Chlorohexanoic acid, 2,2,3,3,4,4,5,5-octafluoropentyl ester
|
|
5 | 1424.00 |
| 26-611-4 |
2-endo,3-exo,5-endo,6-exo,8,8,10-heptachlorobornane
|
|
5 | 2072.60 |
| 26-796-0 |
6-Bromohexanoic acid, 2-methyloct-5-yn-4-yl ester
|
|
5 | 1856.00 |
| 26-916-6 |
Oxetane, 3-bromomethyl-3-[2-methyl-1-(3-methylphenyloxy)propyl]
|
|
5 | 1943.00 |
| 26-951-7 |
(-)-1,2:5,6-Di-O-cyclohexylidene-L-inositol, diacetate
|
|
5 | 2664.50 |
| 27-565-5 |
3H-Pyrido(3,4-b)indole, 4,9-dihydro-6-methoxy-1-methyl-
|
3589-73-9 |
5 | 2242.70 |
|
« Previous Results
Next Results »
|